
Aims of the Committee
Establish close and cordial relationships with national and regional professional organizations in Pathology and allied fields.
Responsibilities
- Explore possibilities of establishing mutually beneficial collaborations with other organizations in education, training and research.
- Recommend to the board of the possibilities of signing new MOUs for such collaborations
- Work closely with the committee on continuing education and quality assurance committee, membership committee, ambassador committee and communication committee
Chair

Dr. Ashish Chandra, MD, MIAC (United Kingdom)
Dr. Ashish Chandra is the lead uropathologist and cytopathologist at Guy’s & St. Thomas’ Hospitals, London where he has been based since 2001. He is a member of the Cytopathology Specialist Advisory Committee at RCPath, is an active member of the British Association of Cytopathology (BAC) and Deputy editor of the journal, Cytopathology.
Members

Dr. Yasin Ahmed, MD, MIAC (UAE)
Dr. Ahmed completed a fellowship in Oncologic Surgical Pathology at Memorial Sloan Kettering Cancer Center in New York and a Cytopathology fellowship at Wayne State University/Detroit Medical Center in Michigan. He also worked as a Clinical Research Fellow in Hematopathology Department at MD Anderson Cancer Center in Texas, USA.
His clinical and academic interests include thyroid and head & neck pathology, lymphoma, gastrointestinal and pancreatobiliary pathology.

Dr. SoonWon Hong, MD, FIAC (Korea)
Dr. Soonwon Hong is a professor of pathology at Yonsei University College of Medicine. She practices at Gangnam Severance Hospital, specizing in thyroid pathology and cytopathology. She led the introduction of The Bethesda System for Reporting Thyroid Cytopathology in Korea.
Dr. Hong served as education director and editorial chairperson, secretary, vice president, president, and auditor of the Korean Society for Cytopathology (KSC) since 2004, and the Korean Society of Pathology, where she also served as editorial chairperson and founded the Endocrine Pathology Research Group.

Dr. Evgenia Kozorezova, MD, MIAC (Russia)
Dr. Evgeniya Kozorezova is the head of cytology department at N.N. Blokhin Russian Cancer Research Center, Moscow. She is a board member at Russian Society of Oncopathology and an active member of the Cytology committee at Laboratory Medicine Federation.

dr. Irem Onur, MD, MIAC (Turkey)
Dr. Irem Onur received her medical degree from the University of Hacettepe, School of Medicine in 1999. She completed her anatomical pathology training in 2004 at Ankara Numune Training and Research Hospital and cytopathology fellowship in 2004 at University of Ege. She did her research fellowship in cytopathology at the Johns Hopkins Hospital, Department of Cytopathology between 2013-2014.
She is the Director of the Department of Cytopathology at Istanbul University-Cerrahpasa, Cerrahpasa School of Medicine since 2019. Currently, she is the president-elect of Turkish Society of Cytopathology and will begin her service in June 2025. She is also a member of International Academy of Cytology.

dr. Samreung Rangdaeng, MD, FIAC (Thailand)
Dr. Bharat Rekhi (MD, DNB, MIAC, FRCPATH) is Professor/Pathologist at Tata Memorial Centre(TMC), Mumbai, India with a special interest in bone and soft tissue tumors (adult and pediatric), gynec pathology and related molecular and cytopathology. He serves on the editorial board of the World Health Organization (WHO)-International Agency for research on cancer (IARC) for reporting system in soft tissue cytopathology. He is a standing committee member for the WHO-IARC books for the 5th and 6th editions. He is one of the members of the tumor harmonization, grey zone and rare tumors and World Health Organization classification of tumors (WCT)/lower middle income country liaison committees for the 6th edition of the WCTs. He is one of the country advisors (North India) for the Royal College of Pathologists, UK.
He has many awards to his credit, including grand prize for the best electronic poster exhibit, International Skeletal Society meeting, Rome, 2012, Dr V.R. Khanolkar award the best published paper in 2018, Smt. Kunti Mehrotra award for the best published paper in 2012, the latter two awards, both by the Indian Association of Pathologists and Microbiologists (IAPM) and for the best oral presentation by the Indian Academy of Cytologists, during the year 2018.
He has 6 National gold medal orations and presented as an invited speaker at numerous National and International Conferences, including International Congress of Cytology (ICC), European Congress of Cytology (ECC), European Congress of Pathology(ECP), International Academy of Pathology (IAP)-Asia Pacific, IAP-Singapore division, USCAP, ESMO-Asia 2019, NUHS surgical pathology course, Singapore, 2019 and College of Pathologists, Sri Lanka, 2022. He was chairperson in sessions on soft tissue and bone tumors during the European Congress of Pathology (ECP) 2020, 2021 and 2022 and also invited for the year 2024. He was also the poster judge for the ECP 2022. He is the Editor-In-Chief of the Indian Journal of Pathology and Microbiology (IJPM), and the current secretary of the Indian Academy of Cytologists.
He has authored/co-authored 285 PUBMED-indexed publications with an overall h-index of 33 and has written several book chapters, including for the 5th edition of the (WHO) classification of Tumors of soft tissue and bone, pediatric and skin tumors. He is on the editorial board of the IARC-WHO reporting system for soft tissue cytopathology. He is an outreach editor for the cytopathology journal, associate editor of BMC Cancer and a recognized MD pathology teacher. He is also on the editorial board of the International Journal of Surgical Pathology and Pathology Research and Practice journals.
Ex-Officio Members

dr. Syed Z. Ali, MD, FRCPath, FIAC (USA)
Prof. Ali serves as Professor of Pathology and Radiology at the Johns Hopkins University School of Medicine as well as the Director of the Division of Cytopathology at The Johns Hopkins Hospital. He received his Pathology residency training at North Shore University Hospital/Cornell University in New York with fellowships in Oncologic Surgical Pathology at Memorial Sloan-Kettering Cancer Center in New York and Cytopathology at The Johns Hopkins Hospital in Baltimore.
Known globally as an innovative educator, Prof. Ali has well over 375 invited lectures, keynote speeches and visiting professorships all over the world. In collaboration with international societies and universities, he directs or co-directs several annual major cytopathology tutorials.
Prof. Ali has published extensively with over 335 peer-reviewed articles in major scientific journals, over 35 books, book chapters and electronic media. Known for his expertise in “Thyroid” and “Pancreatic” cytopathology, his monograph on “The Bethesda System for Reporting Thyroid Cytopathology” (now in its 3rd edition) has been translated in 8 languages and is extensively used in medical practice all over the world. He is the founding editor-in-chief of the Journal of the American Society of Cytopathology (JASC) and a past-President of the American Society of Cytopathology (ASC). Presently, he serves as the President of the International Academy of Cytology (IAC) and Chair of the International Board of Cytopathology of the IAC. He is a fellow of both the Royal College of Pathologists (UK) and the IAC. He is recipient of the ASC’s “Warren R. Lang Award” in 1996, “President’s Award” in 2012, “Excellence in Education Award” in 2015, the IAC’s “Maurice Goldblatt Award” in 2019, Papanicolaou Society of Cytopathology’s “LC Tao Educator of the Year Award” in 2022 and the ASC’s “Papanicolaou Award” in 2023..

Massimo Bongiovanni, MD, FIAC (Switzerland)
Dr. Bongiovanni is head of Cytopathology at SYNLAB Pathology in Lausanne, Switzerland. He is member of the Pathology Expert Group, at SYNLAB International, Member (MIAC) and then Fellow (FIAC) of the International Academy of Cytology since 2016. He is the author of more than 200 scientific articles and 15 book chapters. He was Vice President of the Swiss Cytology Society (2015-2021) and a member of the Endocrine Tumor Group of the European Organisation for Research and Treatment of Cancer (EORTC). He is associate editor of the journal Acta Cytologica and participates in the editorial board of the journal Diagnostic Cytopathology. He is currently co-chair of the scientific committee of the European Federation of Cytology Societies (EFCS).